Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

40
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
40
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

67
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
67
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

643
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
643
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

88
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
88

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas genome editing transforming crop stress tolerance for global food security.

PeerJ·2026
Same author

Vernodalin and <i>Gymnanthemum extensum</i> Crude Extracts Exhibit In Vitro Anticancer Activity with Differential Regulation of Cancer-Associated Signaling Proteins in Breast and Ovarian Cancer Cells.

Biomedicines·2026
Same author

Inoculation fermentation improves the nutritional quality and flavor profile of Chinese traditional fermented okara (Meitauza): a comparison with a commercial benchmark.

Frontiers in microbiology·2026
Same author

Mixed convective transient nanofluid flow through a vertical porous channel with entropy and Navier slip effects.

Discover nano·2026
Same author

Application of Virtual Twin PBPK Models in Individuals with Obesity via CYP3A4 Phenotyping Using Endogenous Biomarker Data.

Clinical pharmacology and therapeutics·2026
Same author

Quantifying Transporter Activity: An Absolute Scaling Approach Using Digoxin.

Molecular pharmaceutics·2026

Related Experiment Video

Updated: Jun 20, 2025

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K

A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator.

Liam Curry1, Sarah Alrubia2,3, Frederic Y Bois1

  • 1Certara Predictive Technologies (CPT), Simcyp Division, Sheffield, UK.

CPT: Pharmacometrics & Systems Pharmacology
|July 20, 2024
PubMed
Summary

Physiologically-based pharmacokinetic (PBPK) modeling predicts drug behavior in specific populations using in vitro data and biological parameters. This tutorial guides creating virtual populations for accurate pharmacokinetic predictions, especially in patient groups where clinical studies are challenging.

More Related Videos

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
10:33

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates

Published on: February 23, 2018

25.2K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.7K

Related Experiment Videos

Last Updated: Jun 20, 2025

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.9K
A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
10:33

A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates

Published on: February 23, 2018

25.2K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.7K

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Computational Biology and Bioinformatics
  • Pharmaceutical Sciences

Background:

  • Physiologically-based pharmacokinetic (PBPK) modeling is crucial for predicting drug behavior.
  • The Simcyp Simulator is a widely adopted software for stochastic PBPK modeling in the pharmaceutical industry.
  • PBPK integrates in vitro data with biological parameters to predict pharmacokinetic changes in diverse populations.

Purpose of the Study:

  • To provide a tutorial on creating virtual populations for PBPK modeling.
  • To detail input parameters and model qualification for robust pharmacokinetic predictions.
  • To illustrate PBPK application with case studies in specific patient groups.

Main Methods:

  • Utilizing the Simcyp Simulator for PBPK modeling.
  • Combining in vitro drug data with physiological and biological parameters.
  • Developing population files for virtual populations, including case studies for obese and Crohn's disease patients.

Main Results:

  • Demonstration of step-by-step population file development for specific patient groups.
  • Highlighting considerations for qualifying PBPK models for various use contexts.
  • Providing a framework for predicting pharmacokinetic changes in populations where clinical studies are not feasible.

Conclusions:

  • PBPK modeling effectively predicts pharmacokinetic changes, filling gaps where clinical studies are impractical.
  • The tutorial offers practical guidance for generating reliable virtual populations.
  • This approach supports informed dosage adjustments and drug development strategies for diverse patient populations.